GIS:FRA
Gilead Sciences, Inc
154,34 €
arrow_upward
+0,10%(+0,16) 1D
18 ნოე, 22:00:00 GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GIS...
Open
154,34 €
High
154,34 €
Low
154,34 €
Mkt. cap
209,59 მლრ.
Avg. vol.
253,00
Volume
13,00
52-wk high
157,14 €
52-wk low
100,42 €
No. of employees
17 ათ.
Open
154,34 €
High
154,34 €
Low
154,34 €
Mkt. cap
209,59 მლრ.
Avg. vol.
253,00
Volume
13,00
52-wk high
157,14 €
52-wk low
100,42 €
No. of employees
17 ათ.
News stories
From web sources and news partners
GuruFocus
·
20 საათის წინ
Gilead Sciences (GILD) CFO Andrew Dickinson Sells 3,000 Shares
Investing.com
·
22 საათის წინ
Gilead Sciences CFO Dickinson sells $514,410 in stock
Yahoo Finance
·
1 დღის წინ
Gilead Sciences (GILD) Grants Royalty Free Ebola Drug Licenses For Lower Income Countries
Profile
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19. It also develops medicines in therapeutic areas such as oncology and inflammation and cell therapy.
In 1987, Michael L. Riordan founded the company under the name Oligogen. The original name was a reference to oligonucleotides, small strands of DNA used to target genetic sequences. Gilead held its initial public offering in 1992, and successfully developed drugs including Tamiflu and Vistide that decade.
In the 2000s, Gilead began evolving from a biotechnology company into a large pharmaceutical company, through acquisitions and investments, acquiring several subsidiaries. Gilead is a member of the Nasdaq-100 and the S&P 100.
The company has faced criticism over its business practices, including extremely high pricing of drugs such as Sovaldi and Truvada in the United States relative to production cost and cost in the developing world. Wikipedia
About Gilead Sciences, Inc
CEOდენიელ ო'დეი
Employees17 ათ.
Founded22 ივნ. 1987
HeadquartersFoster City, კალიფორნია, ამერიკის შეერთებული შტატები
SectorHealth Care
Industry-
Websitegilead.com